Janux Therapeutics Inc. (JANX)
NASDAQ: JANX
· Real-Time Price · USD
24.00
0.69 (2.96%)
At close: Oct 03, 2025, 3:59 PM
24.21
0.88%
After-hours: Oct 03, 2025, 06:26 PM EDT
Janux Therapeutics Revenue
Janux Therapeutics reported an annual revenue of $10.59M, reflecting a 30.99% growth. For the quarter ending June 30, 2025, Janux Therapeutics generated $0 in revenue.
Revenue (ttm)
10.59M
Revenue Growth
30.99%
Price / Sales Ratio
271.8
Revenue / Employee
116.35K
Employees
91
Market Cap
1.44B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 10.59M | +30.99% |
| Dec 31, 2023 | 8.08M | -6.14% |
| Dec 31, 2022 | 8.61M | +136.79% |
| Dec 31, 2021 | 3.64M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |